Swiss National Bank cut its stake in UnitedHealth Group Inc (NYSE:UNH) by 4.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,436,588 shares of the healthcare conglomerate’s stock after selling 142,900 shares during the quarter. UnitedHealth Group makes up approximately 1.0% of Swiss National Bank’s investment portfolio, making the stock its 10th largest position. Swiss National Bank’s holdings in UnitedHealth Group were worth $914,270,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in UNH. Welch Group LLC purchased a new stake in UnitedHealth Group in the 2nd quarter valued at $106,000. FNY Investment Advisers LLC purchased a new position in UnitedHealth Group during the 3rd quarter worth approximately $106,000. Blue Chip Partners Inc. purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $107,000. Fort L.P. purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $119,000. Finally, Polaris Greystone Financial Group LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at approximately $120,000. 85.45% of the stock is owned by institutional investors.
UNH has been the topic of several analyst reports. Citigroup downgraded UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 target price on the stock. in a research note on Monday, September 10th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 18th. Raymond James lifted their target price on UnitedHealth Group from $285.00 to $304.00 and gave the company a “strong-buy” rating in a research note on Monday, September 24th. Bank of America lifted their target price on UnitedHealth Group from $315.00 to $320.00 and gave the company a “buy” rating in a research note on Wednesday, October 17th. Finally, Morgan Stanley lifted their target price on UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a research note on Wednesday, September 5th. Two research analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $289.86.
In related news, CEO Steven H. Nelson sold 26,033 shares of UnitedHealth Group stock in a transaction on Friday, September 7th. The stock was sold at an average price of $270.65, for a total transaction of $7,045,831.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard T. Burke sold 20,000 shares of UnitedHealth Group stock in a transaction on Wednesday, September 12th. The stock was sold at an average price of $263.41, for a total value of $5,268,200.00. Following the transaction, the director now directly owns 1,720,112 shares of the company’s stock, valued at $453,094,701.92. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 54,338 shares of company stock valued at $14,516,459. 0.87% of the stock is currently owned by insiders.
Shares of UNH stock opened at $261.62 on Monday. The firm has a market cap of $251.69 billion, a P/E ratio of 25.98, a PEG ratio of 1.51 and a beta of 0.78. UnitedHealth Group Inc has a 1 year low of $208.48 and a 1 year high of $278.00. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.61.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.30 by $0.11. The firm had revenue of $56.56 billion during the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. UnitedHealth Group’s revenue was up 12.4% on a year-over-year basis. During the same period in the previous year, the firm posted $2.66 earnings per share. As a group, research analysts predict that UnitedHealth Group Inc will post 12.81 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be issued a dividend of $0.90 per share. The ex-dividend date is Friday, November 30th. This represents a $3.60 annualized dividend and a yield of 1.38%. UnitedHealth Group’s dividend payout ratio is presently 35.75%.
COPYRIGHT VIOLATION NOTICE: This story was first posted by Transcript Daily and is the property of of Transcript Daily. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://transcriptdaily.com/2018/11/26/unitedhealth-group-inc-unh-is-swiss-national-banks-10th-largest-position.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: What is Liquidity?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.